Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus

Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus

Hye Rin Jeong, Seong Soo A AnDepartment of Bionano Technology, Gachon Medical Research Institute, Gachon University, Gyeonggi-do, Republic of KoreaAbstract: Human islet amyloid polypeptide (h-IAPP) is a peptide hormone that is synthesized and cosecreted with insulin from insulin-secreting pancreatic...

Full description

Bibliographic Details
Main Authors:	Jeong HR, An SSA
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-11-01
Series:	Clinical Interventions in Aging
Subjects:	Amyloid aggregation Causative factor IAPP (Islet Amyloid Polypeptide) Toxic oligomer T2DM (Type2 Diabetes Mellitus)
Online Access:	https://www.dovepress.com/causative-factors-for-formation-of-toxic-islet-amyloid-polypeptide-oli-peer-reviewed-article-CIA

Similar Items

Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics
by: Andisheh Abedini, et al.
Published: (2016-05-01)

Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation
by: Sanduni Wasana Jayaweera, et al.
Published: (2021-03-01)

Heterologous Expression of Immature Forms of Human Islet Amyloid Polypeptide in Yeast Triggers Intracellular Aggregation and Cytotoxicity
by: Ana F. Raimundo, et al.
Published: (2020-09-01)

Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimer’s disease: two triggers, one disease
by: Sofia Ferreira, et al.
Published: (2021-01-01)

Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo
by: Xiao-Dan Mo, et al.
Published: (2018-03-01)

Type 2 diabetes mellitus as a prion disease (literature review)
by: A.S. Filimonova, et al.
Published: (2022-02-01)

Electrochemical Assay of Human Islet Amyloid Polypeptide and Its Aggregation
by: Genxi Li, et al.
Published: (2008-09-01)

Addition of exogenous sodium palmitate increases the IAPP/insulin mRNA ratio via GPR40 in human EndoC-βH1 cells
by: Camilla Krizhanovskii, et al.
Published: (2017-07-01)

Fibril elongation by human islet amyloid polypeptide is the main event linking aggregation to membrane damage
by: Barend O.W. Elenbaas, et al.
Published: (2023-01-01)

Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes
by: Anne-Cathrine S. Vogt, et al.
Published: (2021-11-01)

Studies on alpha-synuclein and islet amyloid polypeptide interaction
by: Ye Wang, et al.
Published: (2023-01-01)

Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus
by: Elisa S. Roesti, et al.
Published: (2020-03-01)

Disaggregation of Islet Amyloid Polypeptide Fibrils as a Potential Anti-Fibrillation Mechanism of Tetrapeptide TNGQ
by: Raliat O. Abioye, et al.
Published: (2022-02-01)

Islet amyloid polypeptide does not suppress pancreatic cancer
by: Austin J. Taylor, et al.
Published: (2023-02-01)

Contribution of the 12–17 hydrophobic region of islet amyloid polypeptide in self-assembly and cytotoxicity
by: Mathilde Fortier, et al.
Published: (2022-10-01)

Efficacy of IAPP suppression in mouse and human islets by GLP-1 analogue conjugated antisense oligonucleotide
by: Tatyana Gurlo, et al.
Published: (2023-02-01)

Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction
by: Júlia Rodríguez-Comas, et al.
Published: (2020-07-01)

The Inhibition Effect of Epigallocatechin-3-Gallate on the Co-Aggregation of Amyloid-β and Human Islet Amyloid Polypeptide Revealed by Replica Exchange Molecular Dynamics Simulations
by: Xuhua Li, et al.
Published: (2024-01-01)

The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
by: Mohammed Alrouji, et al.
Published: (2023-05-01)

Potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes management
by: Raliat O. Abioye, et al.
Published: (2021-05-01)

The Toxicity and Polymorphism of β-Amyloid Oligomers
by: Ya-ru Huang, et al.
Published: (2020-06-01)

β-Hairpin Peptide Mimics Decrease Human Islet Amyloid Polypeptide (hIAPP) Aggregation
by: Jacopo Lesma, et al.
Published: (2021-09-01)

Undercover Toxic Ménage à Trois of Amylin, Copper (II) and Metformin in Human Embryonic Kidney Cells
by: Terenzio Congiu, et al.
Published: (2021-06-01)

SORLA mediates endocytic uptake of proIAPP and protects against islet amyloid deposition
by: Alexis Z.L. Shih, et al.
Published: (2022-11-01)

Evaluation of Amyloid Polypeptide Aggregation Inhibition and Disaggregation Activity of A-Type Procyanidins
by: Taisei Tanaka, et al.
Published: (2021-10-01)

Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils
by: Martin Muschol, et al.
Published: (2023-02-01)

Washingtonia filifera seed extracts inhibit the islet amyloid polypeptide fibrils formations and α-amylase and α-glucosidase activity
by: Sonia Floris, et al.
Published: (2021-01-01)

Inside the Insulin Secretory Granule
by: Mark Germanos, et al.
Published: (2021-08-01)

Amyloid management by chaperones: The mystery underlying protein oligomers’ dual functions
by: Payam Arghavani, et al.
Published: (2022-01-01)

Chitosan Oligosaccharides Attenuate Amyloid Formation of hIAPP and Protect Pancreatic β-Cells from Cytotoxicity
by: Qin-Yu Meng, et al.
Published: (2020-03-01)

Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets
by: Queenie Hui, et al.
Published: (2017-08-01)

Editorial: Oligomers in amyloid-associated diseases—structural properties and toxicity
by: Neville Vassallo, et al.
Published: (2023-06-01)

Molecular Mechanisms of Amylin Turnover, Misfolding and Toxicity in the Pancreas
by: Diti Chatterjee Bhowmick, et al.
Published: (2022-02-01)

Probing the Occurrence of Soluble Oligomers through Amyloid Aggregation Scaling Laws
by: Alexandra Silva, et al.
Published: (2018-10-01)

Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3β and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer’s Disease
by: Rohith N Thota, et al.
Published: (2020-04-01)

Single Molecule Characterization of Amyloid Oligomers
by: Jie Yang, et al.
Published: (2021-02-01)

Factors That Contribute to hIAPP Amyloidosis in Type 2 Diabetes Mellitus
by: Adriana Sevcuka, et al.
Published: (2022-04-01)

Obesity is associated with impaired postprandial pancreatic polypeptide secretion
by: Yanyun Zhao, et al.
Published: (2023-06-01)

Structural mapping of oligomeric intermediates in an amyloid assembly pathway
by: Theodoros K Karamanos, et al.
Published: (2019-09-01)

The association of circulating amylin with β‐amyloid in familial Alzheimer's disease
by: Han Ly, et al.
Published: (2021-01-01)